Effect of Celecoxib on Perioperative Inflammatory Response in Colon Cancer

NCT01284504 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped low accrual rate; the only participant withdrew after signing consent

Conditions

Colorectal Cancer
Colon Cancer

Interventions

DRUG: Celecoxib
OTHER: placebo

Sponsor

Stanford University